+ All Categories
Home > Documents > Ashg presentation 2010

Ashg presentation 2010

Date post: 03-Jul-2015
Category:
Upload: oxford-gene-technology
View: 655 times
Download: 2 times
Share this document with a friend
66
From Genomic Studies to Cytogenetics Research An Integrated and Standardised Solution Dr. Mike Evans Chief Executive
Transcript
Page 1: Ashg presentation 2010

From Genomic Studies to Cytogenetics Research —

An Integrated and Standardised Solution

Dr. Mike Evans — Chief Executive

Page 2: Ashg presentation 2010

Today’s agenda

Welcome

Designing a genome-wide structural variant search for type 1 diabetes

loci — Stephen Rich, PhD

How to ensure the highest quality CNV results — Mike Evans, DPhil

Updates on ISCA Consortium and Database — David Ledbetter, PhD

Closing remarks

Page 3: Ashg presentation 2010

OGT - provides advanced clinical genetics solutions

- develops innovative molecular diagnostics

Clinical and Genomic SolutionsArray services and cytogenetics products

Technologies

For Molecular

Medicine

Biomarker DiscoveryGenomic- and protein-based diagnostics

IP Licensing

Page 4: Ashg presentation 2010

Clinical and Genomic Solutions

Cytogenetics

• CytoSure™ product range and service

Genomic services

• Genefficiency™ high throughput microarray services

Page 5: Ashg presentation 2010

Today’s agenda

Welcome

Designing a genome-wide structural variant search for type 1 diabetes

loci — Stephen Rich, PhD

How to ensure the highest quality CNV results — Mike Evans, DPhil

Updates on ISCA Consortium and Database — David Ledbetter, PhD

Closing remarks

Page 6: Ashg presentation 2010

Designing a Genome-wideStructural Variant Search for

Type 1 Diabetes Loci

Stephen S. Rich, PhD

November 4, 2010

Page 7: Ashg presentation 2010
Page 8: Ashg presentation 2010
Page 9: Ashg presentation 2010
Page 10: Ashg presentation 2010
Page 11: Ashg presentation 2010
Page 12: Ashg presentation 2010
Page 13: Ashg presentation 2010
Page 14: Ashg presentation 2010
Page 15: Ashg presentation 2010
Page 16: Ashg presentation 2010
Page 17: Ashg presentation 2010
Page 18: Ashg presentation 2010

High-quality, cost effective genomic services for the following

applications:

Service Application Target Market

aCGH Copy Number variation

(CNV) detection / analysis

- GWAS

- Cancer studies

- Molecular psychiatry

miRNA miRNA expression analysis - Biomarker studies

- Cancer research

- Expression studies

Methylation Detecting epigenetic events - Epigenetic studies

- Biomarker studies

Gene

expression

Gene expression analysis - Biomarker studies

- Expression studies

What is Genefficiency™ from OGT?

Page 19: Ashg presentation 2010

Reliably detect biologically significant CNVs

• Performance:

aCGH locates more chromosomal breakpoints at higher resolution than

other methods*

• Platform:

Agilent platform provides superior detection and quantification of CNVs.*

Superior sensitivity through long oligos (60mers)†

• People:

Our dedicated, experienced scientists are available for consultation and

support throughout your project

• Process Power: minimising technical variation

>2,000 samples per week capacity, with >40 QC checks on each sample

and proprietary LIMS, ensures quick delivery of high quality data

*Curtis, C. et al (2009) BMC Genomics 10, 588-610†Ionita-Laza, I. et al (2009) Genomics 93, 22-26

Page 20: Ashg presentation 2010

Genefficiency™ High-Throughput Services

OXFORD GENE TECHNOLOGY

SUCCESSFULLY COMPLETES

WORLD’S LARGEST COPY

NUMBER VARIATION STUDY

Oxford, UK, May 21, 2009 - Oxford

Gene Technology (OGT), the pioneer of

microarray-based technologies, has

successfully completed processing

more than 20,000 samples that

have been generated by the Wellcome

Trust Case Control Consortium

(WTCCC), the world’s largest CNV

study involving a collaboration of 24

leading human geneticists.

Page 21: Ashg presentation 2010

Customer satisfaction...

20,000 samples. 1,000 samples / week

―In order to characterise genetic variants,

reproducible performance and reliable processing

of the high resolution microarrays is essential. We

were pleased with OGT’s responsive approach

and attention to producing high quality data to tight

deadlines‖

Dr Matt Hurles, Wellcome Trust Sanger Institute.‖

Page 22: Ashg presentation 2010

LIMS provides full traceability at every stage

• Customised modules for: plate handling, unique array IDs, hybridisation oven and scanner

• QC on all reagents and consumables: digest and labelling mixes,

incubation block, clean-up kit, cot-1 solution and wash solutions

Page 23: Ashg presentation 2010

Time

DL

RS

*

Wk1 Wk190

0.1

0.2

0.3

0.4

0.5

GOOD

EXCELLENT

POORHeat

block

failure

Purification

module

failure

*DLRS –derivative log ratio spread

This metric is a measure of the quality of the data and hence confidence to detect and call CNV aberrations.

98% Pass rate of Control sample run on every plate for 19 weeks

DLR Spread of Control Samples

Page 24: Ashg presentation 2010

Quality Management System

• Quality management system has been

certified to

• ISO 9001:2008 (Quality management

systems)

• ISO 27001 (Information security)

• ISO 17025 (Laboratory services)

ISO 9001

FS 561156

Page 26: Ashg presentation 2010

CytoSure cytogenetics range

high quality data

meaningful results

standardisation

• Arrays

• ISCA and Syndrome Plus

• Chromosome X

• Aneuploidy

• DMD

• New! ISCA UPD

• Labelling kit

• Software

• Oligome custom arrays

• Hyb buffers, backing plates

• Full automation options

Page 27: Ashg presentation 2010

CytoSure™ Interpret Software - Features

• Data visualisation

meaningful results

Page 28: Ashg presentation 2010

CytoSure™ Interpret Software - Features

• Data visualisation

• Automated aberration detection

meaningful results

Page 29: Ashg presentation 2010

CytoSure™ Interpret Software - Features

• Data visualisation

• Automated aberration detection

• Annotation tracks

meaningful results

Page 30: Ashg presentation 2010

CytoSure™ Interpret Software - Features

• Data visualisation

• Automated aberration detection

• Annotation tracks

• Report generation

• Batch processing

• Data management

• ...and many more – a large number as a result of customer feedback – providing

flexibility in data analysis e.g. User-defined annotation tracks

Syndromes

ExonsGenes

Recomb.

HotspotsCNVs

ConfirmationDecipher

meaningful results

Page 31: Ashg presentation 2010

CytoSure™ Interpret Software - Features

• Data visualisation

• Automated aberration detection

• Annotation tracks

• Report generation

meaningful results

Page 32: Ashg presentation 2010

CytoSure™ Interpret Software - Features

• Data visualisation

• Automated aberration detection

• Annotation tracks

• Report generation

• Batch processing

• Data management

meaningful results

Page 33: Ashg presentation 2010

CytoSure™ Interpret Software - Features

• Data visualisation

• Automated aberration detection

• Annotation tracks

• Report generation

• Batch processing

• Data management

• ...and many more – a large number as a result of customer feedback – providing

flexibility in data analysis e.g. User-defined annotation tracks

meaningful results

Page 34: Ashg presentation 2010

Today’s agenda

Welcome

Designing a genome-wide structural variant search for type 1 diabetes

loci — Stephen Rich, PhD

How to ensure the highest quality CNV results — Mike Evans, Dphil

Updates on ISCA Consortium and Database — David Ledbetter, PhD

Closing remarks

Page 35: Ashg presentation 2010
Page 36: Ashg presentation 2010
Page 37: Ashg presentation 2010
Page 38: Ashg presentation 2010
Page 39: Ashg presentation 2010

“Our recommendation based on current evidence is to offer CMA as the first-tier genetic test, in place of G-banded karyotype, for

patients with unexplained DD/ID, ASD, or MCA.” ISCA Consortium

Yield for clinically significant CNVs in autism/ASD = 5-10%.

(may impact prognosis, identify and direct management

of medical co-morbidities, recurrence risk counseling).

Page 40: Ashg presentation 2010

Published September 2010

Page 41: Ashg presentation 2010
Page 42: Ashg presentation 2010
Page 43: Ashg presentation 2010
Page 44: Ashg presentation 2010
Page 45: Ashg presentation 2010
Page 46: Ashg presentation 2010
Page 47: Ashg presentation 2010
Page 48: Ashg presentation 2010
Page 49: Ashg presentation 2010
Page 50: Ashg presentation 2010
Page 51: Ashg presentation 2010
Page 52: Ashg presentation 2010
Page 53: Ashg presentation 2010
Page 54: Ashg presentation 2010
Page 55: Ashg presentation 2010
Page 56: Ashg presentation 2010
Page 57: Ashg presentation 2010
Page 58: Ashg presentation 2010
Page 59: Ashg presentation 2010
Page 60: Ashg presentation 2010
Page 61: Ashg presentation 2010
Page 62: Ashg presentation 2010

Today’s agenda

Welcome

Designing a genome-wide structural variant search for type 1 diabetes

loci — Stephen Rich, PhD

How to ensure the highest quality CNV results — Mike Evans, DPhil

Updates on ISCA Consortium and Database — David Ledbetter, PhD

Closing remarks & lunch

Page 63: Ashg presentation 2010

CytoSure — excellence from sample to result

• Optimized, double-validated array content — regularly updated to

ISCA specifications

• Reliable detection of CNV and UPD on a single array — CytoSure

ISCA UPD array

• Effortless data analysis — easy-to-use, class-leading software

• Expert, high-throughput cytogenetics aCGH service — CytoSure

Services

The complete solution for cytogenetics — arrays (product or custom),

software, labelling, reagents, automation, services

Page 64: Ashg presentation 2010

OGT can help!

OGT has made major investments in infrastructure and software to support disease and cytogenetics research…

Run your samples using our HT facility

• OGT has an unparalleled track record in delivering high quality data for CNV, methylation, miRNA and gene expression analysis

Design your perfect array

• OGT’s array design expertise and double-validated probes can help you design a custom array to suit your specific needs

Choose your ideal cytogenetics products

• CytoSure delivers the complete solution for cytogenetics — from sample to result

Page 65: Ashg presentation 2010

AcknowledgementsOGT Collaborators and Customers

Page 66: Ashg presentation 2010

Thank you

www.ogt.co.uk

Visit us at booth 1307 for more information


Recommended